Daily Hong Kong Stock Market News Express (Tuesday, May 6)

< br > < span class = "section-news" > 1. Jiangsu Hengrui Pharmaceutical joint stock company passed the listing hearing of the Hong Kong Stock Exchange. The joint sponsors are Morgan Stanley, Citi and Huatai International. < br > < span class = "section-news" > 2. Shiteng Holdings (002565.HK): Reached a strategic cooperation with BytePlus, a subsidiary of ByteDance, to jointly expand the artificial intelligence app store of enterprises in the Asia-Pacific region. < br > < span class = "section-news" > 3. Standard Chartered Group (02888.HK): Operating income under fixed exchange rates increased by 7% to US $5.40 billion in the first quarter; profit attributable to shareholders of the parent company was US $1.59 billion, an increase of 13% year-on-year. < br > < span class = "section-news" > 4. China Electric Power (02380.HK): Affiliated Wuling Power (a subsidiary with 63% equity) achieved operating income and other income of 1.61 billion yuan in the first quarter, and net profit 907 million yuan during the period. < br > < span class = "section-news" > 50,000 Gold Group (03939.HK): Affiliated Jinling Mining and Zijin Engineering entered into a feasibility study contract for the expansion of Jinling Mine by 10 million tons/year. < br > < span class = "section-news" > 6. Hongyang Real Estate (01996.HK): Extend the early restructuring support agreement fee period and the basic restructuring support agreement fee period. < br > < span class = "section-news" > 7. CSPC (01093.HK): JMT202 (recombinant all-human anti-β KLOTHO monoclonal antibody) was approved for clinical trials in the United States.